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goodness of fit statistics was not significant, indicating excellent model dis-
crimination. The model generated (M) was compared with the Northern New
England (NNE), and the Cleveland Clinic (CC) models.
Model NNE had a significantly greater ability to predict mortality in thia
patient population when compared with model CC (p < 0.03). Conclusions:
1) Predictive models for PTCA mortality yield variable results when applied
to patient populations other than the one on which the original model was
developad. 2) Although proper risk adjustment may allow comparisons of
different operators and institutions, case mix may confuse interpretation of
1032-40 ClinicalVariableaPredictCoataandResourca
Utilizationin UnatableAngina
J.E. Calvin, L.W. Klein, B.J. Vandenberg, P.Meyer, J.E. Parrillo. Rush
Medical College, Chicago, IL, USA
In a previous study we developad and validated a model based on early
identified clinical factors that pradiefs risk of major cardiac complications in
unstable angina (UA). To determine whether this model could also predict
resource utilization in UA, 470 patients were prospectively evaluated. The
population was orderad on the basis of estimated risk of major complication
(Ml, death or heart failure) and then divided into 3 groups: Low risk: n
= 72, < 2Yo; Medium risk: n = 286, 2.5-15%; and’ High risk: n = 112, >
15%. Admission to CCU, use of surgery, length of stay (LOS) and direct
hospital costs estimated on basis of payor and DRG code were compared.
Results: High risk patients were more frequently admitted to CCU compared
to medium and low risk patients (80Y0vs 8EIY0,P <0.05 and vs 51%, P
< 0.05; respectively), received coronary surgery more often (27Y0vs 15Y0
and 8%, P c 0.05, respectively), had a higher LOS (10 + 7 days vs 8 + 6
days, P <0.05 and 5 + 3 days, P < 0.005) and total hospital cost ($22,120
+ 22,271 vs $14,542 * 11$333,p <13.135and $9102 + 7138, p < 0.05)
then medium and low rfsk patients, respectively. Low risk patienta had lower
LOS and hospital costs than medium risk patienta (P < 0.05). Conclusions.’
Clinical variables available within the first few hours of admission prediet
subsequent resource utilization and hospital cost. This model can support
cliniesl praoflce guidelines by stra~tying patienta into low, madium and high
risk categories which differentiate both outcome and intensity of treatment.
m103241 PredictorsofNotAdministeringThrombolyticTherapyto EligiblePatientswithAMI
J.E. Murillo, J. Chen, Y.Wang, H.M. Krumholz. YaleUniversity SchoO/of
Medicine, New Haven, Cz USA
Although thrombolytic therapy is acost-effeetive treatment of AMI, the utiliza-
tion rates are markedly low among eligible elderly patients. To evaluate the
factors associated with the deeision not to administer thrombolytic therapy
(lT) in the elderly we used the CT cohort of the Cooperative Cardiovascular
Projeet database which contains medical record information for more than
3,000 Medicare patients with AMI.
Among the 756 patients >65 yeara with either ST-segment elevation in
at least two contiguous leads or LBBB not known to be old, no absolute
contraindications to TTand who were not referred for direct PTCA or CABG,
422 (56%) did not recaive thrombolytic therapy. To predict the decision not to
administer 11 we developed a logistic regression model using demographic
and clinical faotora, preadmission madioations, and ECG characteristics as
the candidate variables, as shown below..The area under the ROC curve
was 0.85 suggesting high predictive power.
Variable OR 95%cl P
Ags,eachyear 0.92 0.90-0.95 0.00
ChestPain>6 hrs 0.26 0.1S-0.38 0.00
ChestPainAbsent 0.26 0.16-0.42 0.00
LBBBNotKnownToBeOld 0.03 . 0.01-0.14 0.00
Ttil STElevstionAmplitudes6 mm 0.37 0.23-0.56 0.00
STElevstionin at least 2 Leads 0.60 0.39-0.93 0.02
OldQWaves 0.56 0.3S-Q.62 0.00
Confusion 0,35 0.15-0.84 0.02. . .. .
Coma 0.07 0.01-0.59 0,02
Cone/usion:Variablesthat suggest alargerinfaretion, prforischemicinjury,
greater risk from the therapy and inability to oonsent to therapy explain a
substantial propodion of the decision not to treat with thrombolytic therapy.
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A SimpleClinicalClassificationCanIdentify
Pstientsat RiskforAdvarsePatientOutcomes
(APO)fromDiagnosticandIrrterventional
Procedures:A ProspectiveEvaluation
B.F.Uretsky, F.Wang, S. Black, D. Cutlar, M.J. Davis, C. deFilippi,
R. Farrell, E.J. Maclnerney, Jr., G. Stouffer. The University of TexasMedical
Branch, Galveston, TX, USA
Stratifying procedural risk is important in developing pt care algorithm and
critiquing physician and Iaboratoty outcomes. We prospectively categorized
as high- or low-risk (HR, LR) 5291 consecutive diagnostic (diag) and 729
interventional (interv) eases. HR pts had > 1: diabetes, age >70 yra, Ml c 6
d, NYHA functional Ill, IV, systolic -=90 or >200 mmHg, peripheral vascular
disease, ejection fraction < 25%, creatinine >1.6 mg%, CPR < 7d, inotropic
or mechanical supporL unstable angina, aorfic stenosis, CVA <4 wks, or
bleeding diathesis LR = no HR features.
‘h DiagAPO % IntervAPO
LR(n= 2634) HR(n= 2457) LR (n = 262) HR(n= 467)
Death o 0.12 0 n176----
Ml (Q, non-Q) 0.07 0.12 1.9 3.4
CASG o 0.08 0 7.7+
CVA 0.14 0.44” o 0
Arrhythmia 0.3 0.69” 1.5 1.9
HI 0.03 0.49”” o 0.21
Vascular 0,85 2,5”” 2.3 2n---
AllAPOS 1,4 4,6*” 5,7 11.6**
*p<o.05, **p <0.001 HR va LR; HI = hemodynamicinstabilityrequiringtreatment.
Conclusion: A simple pre-procedural clinical classification can to a great
extent differentiate LR from HR pts for cash-related APO.
These data may be used in defining LR pts for outpatient caths and
evaluating physician and laborato~ performance.
-[ UeeofArtifiCia,NeLJra,NetWOrkstOpredict
MortalityAfterPTCA
R.V. Freeman, D.W.M. Muller, E.R. Bates, S.W. Werns, E. Kline-Rogers,
D.J. Karavite, K.A. Eagle, M. Moscucci. University of Michigan Heart Care
Program, Ann Arboc Ml, USA
Logistic regression models of percutaneous transluminal coronary angio-
plasty (PTCA) mortality are limited by their relative inability to predict out-
comes for individual patients and by low sensitivity. Artificial neural networks
(NN) are computer constructs that can detect complex patterns within a data
set and have been useful in pattern recognition for outcome prediction mcff-
els. This study examined the application of a NN in predicting moflality in
patients undergoing PTCA. A NN was trained on 82 clinical input variables
collected from 1250 consecutive PTCA procedures. Cross validation was
done by dividing the database into three training and test sets. Final valida-
tion was done by running the NN on an additional 224 patients not used in
the training or test phase of NN construction. Positive multivariate predictors
of in-hospital mortality included age, heart failure, renal failure, hemodialysis,
unstable angina, number of diseased vessels, oardiogenic shook, ventricular
tachycardia or fibrillation, LAD lesion, pre-procedure heparin, IABP support
requirement,vasopressor suppofl requirement, and urokinase during the pro-
cedure. Multivariate predictors of in-hospital survival included pre-prooedure
aspirin, pre-procedure t-PA and post-procedure beta-blocker administration.
On the training database, the NN for mortality performed with sensitivity
(s) = S4.1%, a positive prediotiva vaiue (PPV) = 78.7%, and specificity
(sp) = 99.2%. A logistic regression model constructed on the same training
database hads = 31.8%, PPV = 56%, and sp = 99.1%. The NN preserved its
accuracy in the independent validation set withs = 42.9%, PPV = 75.0%, and
Sp = 99.59’..The lower sensitivity seen on the independent validation set was
largely attributable to the low number of events (deaths= 7) observed in the
validation set. Conclusion: Artificial neural networks may provide a valid and
possibly more accurate alternative to conventional logistic regression models
for PTCA mortality assessment, and for predicting outcomes for individual
patients.
m103244 TheFinancialImpactof Stentingis DependentonClinicalEfficacyandPayerMix
P.T.Vaitkus, W.T.Witmer, R.G. Brandenburg. The Univarsify of Vermont,
Burlington, VT USA
Previous studies have focused exclusively on costs of stents, ignoring costs
of prevented complications and ignoring associated revenues. We assess
the cost effectiveness of bailout stenting from the perspective of the provider
organization: how clinically effective does stenting need to be to achieve
